Rocket Lab's $397 Million Space Force Win Masks a Simpler Truth: Everything Still Rides on Neutron
Published on 08/05/2026 at 13:22 | Redaktion boerse-global.de
The headline number is hard to ignore. On August 4, 2026, the US Space Force handed Rocket Lab a $397 million contract to develop, launch, and operate a constellation of "flatellite" spacecraft under the Space-Based Airborne Moving Target Indicator program. It marks the first publicly confirmed mission for the company's upcoming Neutron rocket, and it validates a strategic shift: Rocket Lab is no longer just a launch provider, but a full-service defense contractor building and operating its own hardware.
The market responded with enthusiasm. Over seven trading days, the stock climbed 29.69 percent to €66.40. Yet that rally masks a more complicated picture. Even after the surge, the shares sit more than 50 percent below their late-May 52-week high, and the stock has spent the summer whipsawing between sharp gains and brutal drawdowns. Over the past 30 days, the shares are still down roughly 18 to 20 percent depending on the measurement date, with an annualized volatility reading north of 96 percent. This is not a stock that has found its footing — it is one that is still deciding which direction to go.
The Bull Case: A Defense Pipeline Takes Shape
The Space Force award is the latest in a string of military wins. Rocket Lab recently secured a $266 million contract for suborbital launches and a $190 million hypersonic test deal, positioning the company as a central supplier to US military infrastructure. Each contract pushes the company further into higher-margin service territory, where it controls both the hardware and the operations.
Optimists also point to the planned $8 billion acquisition of Iridium, expected to close in mid-2027. Combined with a backlog that has grown to $2.2 billion, the deal could deliver the recurring revenue needed to push Rocket Lab into GAAP profitability. Wall Street's consensus price target stands at €99.31, implying upside of roughly 50 percent from current levels if the major projects stay on schedule.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The Bear Case: Execution Risk Is Piling Up
The flip side is that Rocket Lab is now juggling two massive initiatives simultaneously. Neutron must reach the launch pad while the company simultaneously integrates a multibillion-dollar acquisition. Any delay to the rocket's first flight, currently targeted for late 2026, would not only jeopardize the SB-AMTI mission but also threaten the broader Space Systems business, which now accounts for the majority of revenue.
There are other caution flags. The stock remains 1.63 percent below its 200-day moving average of €67.50, and it has yet to fully recover from a 30-day drawdown of 18.43 percent. CEO Peter Beck has also sold roughly 3.29 million shares over the past six months — insider selling of that magnitude tends to give some investors pause.
Neutron Is the Real Catalyst — and It's Closer Than It Looks
Strip away the contract news and the sector dynamics, and the entire investment thesis for Rocket Lab comes down to one project. Neutron, the reusable medium-lift rocket designed to compete with SpaceX's Falcon 9, is the key to everything. Beck has signaled that investors should watch for "placement of components on test stands" as the next progress marker, and he describes the timeline for a first launch in Q4 2026 as "aggressive."
The technical signs are encouraging. Beck reports "significant progress" on refining the stage-one tank design, and the second stage and interstage system have already completed separation maneuvers under full flight loads. These are concrete milestones, not marketing language.
Analysts increasingly frame the first Neutron launch as a re-rating catalyst rather than an immediate revenue driver. The rocket likely won't contribute meaningfully to financial results until 2027 or 2028, but markets begin pricing future cash flows well in advance. That logic suggests the first flight in 2026 could move the stock more than the first commercial customer launch a year later. If that holds, the current share-price weakness may reflect investor impatience more than doubt about the underlying business model.
Wall Street Is Split — and That's Telling
The consensus target of €99.31 looks impressive on paper, but it hides an important nuance. Piper Sandler's Alexander Potter initiated coverage with a Hold rating and a price target signaling only modest upside. His hesitation isn't about execution — he explicitly praises Beck and the team for building Rocket Lab into the leading SpaceX alternative. His caution is about valuation. The stock is simply too expensive for him, even though he sees Neutron as a genuine long-term growth driver.
That split — bullish on strategy, cautious on price — captures the current moment reasonably well.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
What Happens Next
The immediate test comes quickly. Rocket Lab reports second-quarter results on August 10, 2026, with management guiding for revenue between $225 million and $240 million, another sequential record. Adjusted EBITDA is expected to remain negative as the company continues heavy investment in Neutron. Shareholders will be hoping for a repeat of the first quarter, when better-than-expected results sent the stock up 34 percent.
If management can offer a credible window for the first Neutron launch, the consensus target of €99.31 could come back into reach. If the numbers instead point to rising development costs or fresh delays, last week's rally could evaporate as quickly as it appeared.
With an RSI of 47.4, the market is neither overbought nor oversold — it's undecided. The stock has clawed its way back to within 4.36 percent of its 200-day average, but it remains more than 20 percent below its 50-day average of €80.99. That gap tells the story of a stock that has recovered from a brutal summer sell-off without establishing any clear direction.
Two dates will settle the question: the upcoming earnings report and, ultimately, Neutron's debut on the launch pad. Until then, Rocket Lab remains a stock for investors with strong stomachs and a clear view of what they're betting on.
Ad
Rocket Lab Stock: New Analysis - 5 August
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
